Just how much of a difference does it make to order exome sequencing first?
For patients with seizures, there’s a real difference between ordering exome sequencing first and starting with a multi-gene panel or chromosomal microarray (CMA).
Happy holidays! Please be advised that in-transit patient samples will be held by the carrier on Dec. 25 and received by our lab the next day. Kit orders placed on Dec. 25 will be sent on Dec. 26. Our genetic counseling services, client services, and billing services will be unavailable Dec. 24-25; please leave us a message at 888-729-1206 or support@genedx.com and we will respond when we return.
For patients with seizures, there’s a real difference between ordering exome sequencing first and starting with a multi-gene panel or chromosomal microarray (CMA).
This Epilepsy Awareness Month, we’re shining light on the genetic causes of seizures.
Findings from the first 4,000 newborns screened using GeneDx genome sequencing, were published today in the Journal of the American Medical Association (JAMA).
Ben’s illness started with seizures when he was just six-months old.
His mother, Ashley, never stopped searching for answers—and finally found them with a genome test.
Leveraging our expansive genomic database, we’re working to transform care for pediatric patients. See GeneDx research being presented at the American Association of Human Genetics Annual Meeting.